Random urine drug testing among patients receiving opioid therapy for cancer pain.
Joseph A ArthurMichael TangZhanni LuDavid HuiKristy NguyenEden Mae RodriguezTonya EdwardsSriram YennuShalini DalalRony DevAkhila ReddyKimberson TancoAli HaiderDiane D LiuEduardo BrueraPublished in: Cancer (2020)
Approximately 1 in 4 patients receiving opioids for cancer pain at a supportive care clinic who underwent random UDT had 1 or more abnormalities. Random UDT detected abnormalities earlier than the targeted test. These findings suggest that random UDT is justified among patients with cancer pain.